Fresh analysis reveals that people who discontinue blockbuster slimming jabs like semaglutide or tirzepatide can put back on lost weight at a significantly accelerated pace than those who stop conventional lifestyle programs.
Research printed in a prominent medical journal points out that while overweight individuals often shed substantial amounts of their total mass while using the jabs, the weight is regained at an average rate of 0.8 kg per month upon discontinuation.
"Users buying these drugs should be cognizant of the risk of fast weight regain when the medication is stopped," stated lead investigator Dr. Susan Jebb.
Such speed of recovery means a reversion to pre-treatment weight within about a year and a half.
Weighing Treatments
The study, which reviewed dozens of studies involving over 9,000 of patients, contrasted the outcomes of GLP-1 agonists with other pills.
Scientists point out that people who shed pounds through dieting usually experience a more gradual weight regain—approximately 0.1 kg a month—after stopping.
Understanding the Rapid Rebound
Doctors propose the way of the injections is key to understanding the accelerated rebound.
These medications imitate a body's own chemical called glucagon-like peptide-1, which moderates feelings of fullness.
"Artificially providing GLP-1 concentrations far above than normal might result in the body to produce less of its endogenous GLP-1, and could reduce sensitivity to its actions," explained Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this hormone supplement leads to hunger is unsuppressed, making overeating a significant risk."
A Lifelong Condition?
Medical guidelines advise the injections for people with weight-linked health risks, alongside prescribed diet and exercise modifications.
Many experts argue that, given the significant potential of relapse, the therapy should be considered long-term.
This opinion is supported by pharmaceutical companies, who state that the results "underscore the long-term nature of obesity," akin to managing conditions like hypertension.
Patient Testimonies
Users who have come off the jabs report a sudden resurgence of appetite.
"It felt as if a trigger that goes on and you're instantly ravenous," recalled a patient.
The struggle is exacerbated if users have not adopted lasting lifestyle or habit changes during treatment.
Significant Use
Recent estimates show that millions of people in the UK have used these injections in the past year, with desire being substantial.
- Adoption is greater among women compared to males.
- The 40s and 50s age group shows the greatest level of interest.
- Many access the drugs through private prescriptions rather than public health services.
In conclusion, clinicians emphasize that while the jabs are effective agents for weight loss, they are not a magic cure and lasting health benefits likely depends on integrated behavioural management.
